Skip to main content

Table 2 Signal detection for CDK4/6 inhibitors-associated musculoskeletal toxicities (top 30 PTs)

From: Musculoskeletal adverse events associated with CDK4/6 inhibitors: a real-world study using FDA Adverse Event Reporting System (FAERS) database

PTs

All

Palbociclib

Ribociclib

Abemaciclib

Case reports

ROR (95% CI)

Case reports

ROR (95% CI)

Case reports

ROR (95% CI)

Case reports

ROR (95% CI)

Arthralgia

2784

1.42 (1.37, 1.48)

2209

1.52 (1.45, 1.6)

485

1.07 (0.97, 1.18)

90

1.59 (1.26, 2)

Back pain

1934

1.81 (1.73, 1.9)

1421

1.76 (1.67, 1.86)

472

2.12 (1.93, 2.34)

41

1.31 (0.95, 1.81)

Pain in extremity

1906

1.36 (1.3, 1.43)

1370

1.29 (1.22, 1.37)

488

1.73 (1.57, 1.91)

48

1.23 (0.91, 1.66)

Bone pain

1249

4.72 (4.45, 5.01)

935

4.67 (4.36, 5)

283

5.14 (4.55, 5.81)

31

4.19 (2.91, 6.03)

Muscle spasms

821

0.92 (0.85, 0.98)

663

0.99 (0.92, 1.07)

110

0.59 (0.49, 0.71)

48

2.12 (1.57, 2.86)

Myalgia

737

0.96 (0.89, 1.03)

615

1.07 (0.98, 1.16)

99

0.59 (0.48, 0.72)

23

1.07 (0.7, 1.63)

Muscular weakness

404

0.78 (0.71, 0.86)

313

0.8 (0.72, 0.9)

72

0.66 (0.52, 0.83)

19

1.35 (0.85, 2.13)

Arthritis

381

0.97 (0.88, 1.07)

338

1.15 (1.03, 1.28)

35

0.4 (0.29, 0.56)

8

0.68 (0.34, 1.37)

Joint swelling

334

0.53 (0.47, 0.59)

265

0.56 (0.49, 0.63)

56

0.38 (0.3, 0.5)

13

0.67 (0.39, 1.17)

Musculoskeletal chest pain

291

4.15 (3.69, 4.67)

200

3.76 (3.26, 4.33)

87

5.81 (4.69, 7.2)

4

1.95 (0.73, 5.23)

Musculoskeletal stiffness

282

0.62 (0.55, 0.69)

229

0.67 (0.59, 0.76)

44

0.43 (0.32, 0.58)

9

0.66 (0.34, 1.28)

Mobility decreased

268

0.74 (0.65, 0.83)

180

0.66 (0.57, 0.76)

69

0.89 (0.7, 1.13)

19

1.85 (1.17, 2.93)

Neck pain

261

0.98 (0.87, 1.11)

201

1.01 (0.88, 1.16)

57

1.01 (0.77, 1.31)

3

0.39 (0.13, 1.23)

Musculoskeletal pain

255

1.01 (0.89, 1.14)

214

1.13 (0.98, 1.29)

38

0.8 (0.58, 1.1)

3

0.5 (0.16, 1.54)

Limb discomfort

252

1.4 (1.24, 1.59)

175

1.29 (1.11, 1.5)

70

1.81 (1.43, 2.3)

7

1.34 (0.64, 2.83)

Spinal pain

220

3.25 (2.84, 3.72)

110

2.13 (1.76, 2.57)

107

7.26 (5.98, 8.82)

3

1.45 (0.47, 4.53)

Bone disorder

203

2.92 (2.54, 3.36)

138

2.62 (2.21, 3.11)

63

4.38 (3.41, 5.62)

NA

NA

Osteonecrosis of jaw

191

1.63 (1.41, 1.88)

141

1.6 (1.35, 1.89)

33

1.47 (1.04, 2.07)

17

6.07 (3.74, 9.86)

Arthropathy

178

0.61 (0.53, 0.71)

158

0.72 (0.62, 0.85)

18

0.27 (0.17, 0.43)

NA

NA

Osteoporosis

147

0.7 (0.59, 0.82)

101

0.64 (0.52, 0.77)

43

0.86 (0.63, 1.16)

3

0.43 (0.14, 1.35)

Joint stiffness

134

1.06 (0.89, 1.25)

113

1.19 (0.99, 1.43)

18

0.65 (0.41, 1.03)

3

0.82 (0.26, 2.55)

Pain in jaw

131

0.92 (0.78, 1.1)

108

1.02 (0.84, 1.23)

16

0.54 (0.33, 0.87)

7

1.81 (0.86, 3.82)

Musculoskeletal discomfort

122

1.39 (1.16, 1.66)

87

1.32 (1.07, 1.63)

33

1.8 (1.28, 2.54)

NA

NA

Bone lesion

122

8.66 (7.2, 10.41)

34

3.04 (2.17, 4.28)

87

28.08 (22.55, 34.97)

NA

NA

Osteoarthritis

105

0.53 (0.44, 0.65)

80

0.54 (0.44, 0.68)

25

0.57 (0.38, 0.84)

NA

NA

Spinal disorder

86

1.97 (1.59, 2.44)

54

1.64 (1.25, 2.14)

31

3.26 (2.29, 4.65)

NA

NA

Back disorder

77

0.98 (0.78, 1.23)

71

1.21 (0.95, 1.52)

6

0.36 (0.16, 0.8)

NA

NA

Pathological fracture

67

3.23 (2.54, 4.12)

47

3 (2.25, 4.01)

16

3.36 (2.05, 5.5)

4

6.25 (2.33, 16.74)

Osteopenia

64

0.81 (0.63, 1.03)

50

0.84 (0.63, 1.11)

12

0.61 (0.35, 1.08)

NA

NA

Musculoskeletal disorder

56

0.55 (0.42, 0.71)

53

0.69 (0.53, 0.91)

3

0.14 (0.05, 0.44)

NA

NA

  1. Notes NA not applicable